If you want the shortest useful answer: the cannabis-based medicine with the strongest trial record in multiple sclerosis is nabiximols, an oromucosal spray that delivers close to equal parts THC and CBD, and it is used mainly to calm muscle spasticity rather than to treat MS itself. That is the top pick, and it wins on four criteria: the volume of controlled trial data behind it, whether a regulator has reviewed it, how well patients tolerate it, and how consistently it can be dosed. Everything below is sorted against those four criteria.
best strains for multiple sclerosis
The short answer for MS
Medical cannabis is not a treatment for multiple sclerosis. It does not slow relapses, repair myelin, or change the course of the disease. What it may do is reduce certain symptoms, most consistently spasticity and the muscle tightness, spasms, and sleep disruption that come with it. Several reviews of controlled trials found that cannabis-based medicines reduced patient-reported spasticity and spasm frequency compared with placebo, though the quality of that evidence is described as low to moderate, and the symptom relief is modest rather than dramatic. Pain, bladder urgency, and tremor have weaker or mixed support.
Cannabis for Multiple Sclerosis Research
What cannabis does and does not do for MS
Patients often start using cannabis for one specific problem and discover it helps another. Keep the two categories separate when you talk to a neurologist:
- Reasonable target symptoms: spasticity, painful muscle spasms, spasticity-related sleep problems, and in some patients, central neuropathic pain.
- Unsupported or unproven targets: reducing relapse rate, halting disability progression, restoring walking speed, or replacing disease-modifying therapy.
- Mixed evidence: bladder dysfunction, tremor, and general quality-of-life scores. Some trials show small gains, others show none.
The single most important point: never stop or reduce a disease-modifying therapy because cannabis is making you feel better. Symptom relief and disease control are different jobs handled by different drugs.
Option 1: Nabiximols oromucosal spray (top pick)
This is a standardized extract formulated at roughly a 1:1 THC to CBD ratio, sprayed under the tongue or inside the cheek. Because each spray delivers a known amount of each cannabinoid, you and your doctor can titrate one spray at a time until you find the lowest dose that works. That dose control is why it tops this list. It is approved for MS spasticity in a number of countries, and it is the formulation most trials have tested.
Pros
- Consistent, measurable dosing without smoking or vaping.
- The most studied cannabinoid formulation for MS spasticity.
- Titration is gradual, which makes side effects easier to catch early.
- The CBD component may soften some THC side effects.
Cons
- Not approved as a medicine in the United States, so access depends on state programs and product availability.
- Onset takes 15 to 40 minutes or more, which is slow for acute spasms.
- Can cause dizziness, dry mouth, fatigue, and a sense of intoxication.
- Cost is often out of pocket.
Best for: someone with stable, daily spasticity who wants a repeatable dose and does not want to inhale anything.
Option 2: Oral THC and synthetic cannabinoids
Dronabinol and nabilone are synthetic or plant-derived THC products available by prescription for other indications in the US, and some patients use them off-label. Onset runs one to two hours, effects last longer than inhaled forms, and the dose is exact.
Pros
- Pharmaceutical-grade consistency and a prescription trail.
- Long duration can cover a whole night of spasms.
- No inhalation risk.
Cons
- Strong psychoactive effect for many patients.
- Slow onset makes overdose-by-impatience a real problem.
- Not specifically approved for MS in the US.
Best for: nighttime spasticity and sleep disruption in a patient who tolerates THC and wants a single evening dose.
Option 3: CBD-dominant products
High-CBD, low-THC tinctures and capsules appeal to patients who want to avoid intoxication. CBD is generally well tolerated.
Pros
- Little to no psychoactive effect at typical doses.
- Easy to add alongside existing medications.
- Widely available in legal markets.
Cons
- Evidence for CBD alone in MS spasticity is thin compared with THC-containing products.
- Label accuracy varies, so third-party testing matters.
- CBD can raise blood levels of some drugs by affecting liver enzymes.
Best for: a patient who cannot tolerate THC or who is cannabis-naive and wants to test tolerance first.
Option 4: Inhaled flower or vaporized oil
Inhalation acts within minutes, which suits unpredictable spasms.
Pros
- Fast onset, easy to adjust in the moment.
- Wide strain and ratio selection in legal states.
Cons
- Hard to dose consistently from one session to the next.
- Smoke irritates lungs; vapor is gentler but not risk-free.
- Short duration means frequent re-dosing.
Best for: breakthrough spasms or spasm episodes that need fast relief when oral options are too slow.
Side effects and interactions to plan for
Common effects include dizziness, drowsiness, dry mouth, impaired concentration, and low mood. Falls are a genuine concern in MS, and cannabis can worsen balance and reaction time, so driving and stairs need an honest conversation. THC carries a risk of dependence and, in people with a personal or family history of psychosis, a risk of psychiatric symptoms. Cannabis can interact with muscle relaxants, benzodiazepines, opioids, and some anticonvulsants, and it can add to sedation and respiratory depression. Tell every prescriber what you use, including over-the-counter CBD.
Legal reality in the US
Cannabis remains illegal under federal law, though many states permit medical use. No cannabis product is FDA-approved to treat MS. Medical programs usually require a qualifying condition, and spasticity or chronic pain may or may not be on your state's list, so check the current rules where you live before assuming access.
Questions to ask your neurologist
- Is my spasticity severe enough that a cannabinoid is worth trying alongside my current regimen?
- Which of my medications could interact with THC or CBD?
- What dose should I start at, and how slowly should I increase it?
- What improvement would count as success, and when do we stop if it does not happen?
A trial period of four to eight weeks with a written log of dose, timing, and symptoms gives you and your doctor something real to judge. If spasticity does not budge and side effects do, stopping is a reasonable result, not a failure.